|
End-of-day quote
Buenos Aires S.E.
30/09/2026
|
5-day change | 1st Jan Change | ||
| 57,625.00 ARS | -1.79% |
|
+2.13% | +8.57% |
| 09-30 | Merck's experimental skin disease drug succeeds in mid-stage study | RE |
| 09-30 | Major drugmakers turn to China for licensing deals | RE |
| Market Cap | 273B 416,618B 241B 228B 206B 389B 26,186B 394B 2,733B 1,052B 13,393B 1,026B 1,004B 43,013B | P/E 2026 * |
20.4x | P/E 2027 * | 17x |
|---|---|---|---|---|---|
| Enterprise Value | 305B 464,536B 269B 255B 230B 434B 29,198B 439B 3,047B 1,173B 14,933B 1,144B 1,119B 47,961B | EV / Sales 2026 * |
5.28x | EV / Sales 2027 * | 4.91x |
| Free-Float |
91.66% | Yield 2026 * |
3.03% | Yield 2027 * | 3.16% |
| Markets | Quality | ||
|---|---|---|---|
Buenos Aires S.E.
| NVS | End-of-day quote | |
Buenos Aires S.E.
| NVSD | End-of-day quote |
Last Transcript: Novartis AG
| 1 day | -1.79% | ||
| 1 week | +2.13% | ||
| Current month | -5.10% | ||
| 1 month | -6.45% | ||
| 3 months | -5.53% | ||
| 6 months | +5.16% | ||
| Current year | +8.57% |
| 1 week | 57,550 |  | 59,650 |
| 1 month | 54,500 | | 65,050 |
| Current year | 52,150 | | 67,200 |
| 1 year | 43,680 | | 67,200 |
| 3 years | 19,045 | | 67,200 |
| 5 years | 3,743.5 | | 67,200 |
| 10 years | 1,961 | | 67,200 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 01/02/2018 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 16/03/2026 |
Karen Hale
CMP | Compliance Officer | 58 | 14/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 01/01/2015 |
| Director/Board Member | 69 | 01/01/2016 | |
Ton Büchner
BRD | Director/Board Member | 61 | 01/01/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.79% | +2.13% | - | - | 275B | |
| -2.33% | -1.12% | +59.27% | +115.42% | 1,056B | |
| -1.06% | -1.65% | +45.77% | +69.98% | 645B | |
| -0.65% | -1.36% | +17.22% | +75.49% | 465B | |
| -2.66% | -3.71% | +84.92% | +41.15% | 368B | |
| -0.06% | -4.12% | +36.31% | +39.39% | 335B | |
| -0.79% | +3.01% | +21.11% | +27.79% | 275B | |
| -1.19% | -3.09% | +10.75% | +10.61% | 255B | |
| -0.50% | +2.75% | +53.85% | +56.84% | 229B | |
| -1.47% | -2.37% | +32.35% | +98.89% | 188B | |
| Average | -0.43% | +0.12% | +40.17% | +59.51% | 423.98B | |
| Weighted average by Cap. | -0.07% | +0.30% | +44.68% | +71.39% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.67B 87,915B 50.9B 48.18B 43.48B 82.08B 5,526B 83.04B 577B 222B 2,826B 217B 212B 9,077B | 61.43B 93,643B 54.21B 51.32B 46.31B 87.43B 5,886B 88.45B 614B 236B 3,010B 231B 226B 9,668B |
| Net income | 14.21B 21,662B 12.54B 11.87B 10.71B 20.23B 1,362B 20.46B 142B 54.7B 696B 53.35B 52.19B 2,236B | 15.78B 24,060B 13.93B 13.18B 11.9B 22.46B 1,512B 22.73B 158B 60.75B 773B 59.26B 57.97B 2,484B |
| Net Debt | 31.43B 47,918B 27.74B 26.26B 23.7B 44.74B 3,012B 45.26B 314B 121B 1,540B 118B 115B 4,947B | 28.26B 43,082B 24.94B 23.61B 21.31B 40.22B 2,708B 40.69B 283B 109B 1,385B 106B 104B 4,448B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/09/26 | ARS 57,625.00 | -1.79% | 126 |
| 29/09/26 | ARS 58,675.00 | -1.22% | 160 |
| 28/09/26 | ARS 59,400.00 | +1.02% | 860 |
| 25/09/26 | ARS 58,800.00 | +1.60% | 896 |
| 24/09/26 | ARS 57,875.00 | +1.00% | 1,810 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NOVN Stock
- NVS Stock
Select your edition
All financial news and data tailored to specific country editions
